Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 October 2001:
Vol. 294. no. 5542, p. 500
DOI: 10.1126/science.294.5542.500
Prev | Table of Contents | Next

News Focus

BIOTERRORISM:
Blocking Smallpox: A Second Defense

Jon Cohen

Variola, the virus that causes smallpox, was destined for obliteration 6 years ago when a select group of researchers took a new interest in it. The team extensively studied a promising antiviral treatment for variola infection that might be useful in containing an outbreak. They also demonstrated for the first time that the virus can cause fulminant disease in a species other than humans. But their work has been controversial, in part because it raises a question about the World Health Organization plan to destroy all known stocks of variola.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Vaccinia Virus Entry, Exit, and Interaction with Differentiated Human Airway Epithelia.
P. D. Vermeer, J. McHugh, T. Rokhlina, D. W. Vermeer, J. Zabner, and M. J. Welsh (2007)
J. Virol. 81, 9891-9899
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)